4//SEC Filing
SMITH IAN F 4
Accession 0001197032-25-000004
CIK 0001623526other
Filed
Oct 13, 8:00 PM ET
Accepted
Oct 14, 4:16 PM ET
Size
8.1 KB
Accession
0001197032-25-000004
Insider Transaction Report
Form 4
SMITH IAN F
DirectorInterim CEO
Transactions
- Award
Stock Option (Right to Buy)
2025-10-08+570,000→ 570,000 totalExercise: $30.50Exp: 2035-10-07→ Common Stock (570,000 underlying) - Award
Restricted Stock Units
2025-10-08+380,000→ 380,000 totalExp: 2029-10-06→ Common Stock (380,000 underlying)
Footnotes (3)
- [F1]The option shall vest as to 1/4 of the total award on October 6, 2026, with an additional 1/48 of the total award vesting monthly thereafter, subject to the reporting person's continued service to the Issuer on each vesting date.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
- [F3]The award shall vest as to 1/4 of the total award annually on the sixth calendar day of October, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on October 6, 2026.
Documents
Issuer
Stoke Therapeutics, Inc.
CIK 0001623526
Entity typeother
Related Parties
1- filerCIK 0001197032
Filing Metadata
- Form type
- 4
- Filed
- Oct 13, 8:00 PM ET
- Accepted
- Oct 14, 4:16 PM ET
- Size
- 8.1 KB